Novel Pharmaceutical Options For Treating Fibromyalgia.

about

Illness perceptions and burden of disease in fibromyalgia.

P2860

Q38558687-B0DAB105-5113-4BDF-966E-3A71CFCEA04B

P2860

Novel Pharmaceutical Options For Treating Fibromyalgia.

Item

http://www.wikidata.org/entity/Q38705677

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Novel Pharmaceutical Options For Treating Fibromyalgia.

@en

type

Item

label

Novel Pharmaceutical Options For Treating Fibromyalgia.

@en

prefLabel

Novel Pharmaceutical Options For Treating Fibromyalgia.

@en

P1476

Novel Pharmaceutical Options For Treating Fibromyalgia.

@en

P2093

Alberto Batticciotto

http://www.w3.org/2001/XMLSchema#string

Fabiola Atzeni

http://www.w3.org/2001/XMLSchema#string

Manuela Di Franco

http://www.w3.org/2001/XMLSchema#string

Maria Chiara Gerardi

http://www.w3.org/2001/XMLSchema#string

Rossella Talotta

http://www.w3.org/2001/XMLSchema#string

P2860

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

A framework for fibromyalgia management for primary care providers

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

Peripheral pain mechanisms in chronic widespread pain.

Physical therapy modalities in management of fibromyalgia.

Imaging pain of fibromyalgia.

Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials.

Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study.

Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial.

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.

P304

559-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2016.1145052

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Piercarlo Sarzi-Puttini

P577

2016-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26794309

http://www.w3.org/2001/XMLSchema#string

P921

fibromyalgia

Novel Pharmaceutical Options For Treating Fibromyalgia.

about

P2860

P2860

Novel Pharmaceutical Options For Treating Fibromyalgia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921